WGS News | Roxom Stocks

Invest Private Security Newsroom

Market Overview

Indices and commodities.

Bitcoin treasury preferreds.

The artificial intelligence theme.

Bitcoin Treasuries

Companies holding bitcoin.

Sectors, global markets and rates.

Popular Portfolios

13F filings, smart money.

Borrow USDT or USDC against your BTC without giving it up.

Switch your bitcoin-backed loan and pay less interest.

Borrow, invest, keep the spread.

Stock Dividends

Dividends from tokenized equities.

Company

Our leadership team, mission, and investors.

Vision, purpose, and architecture behind Roxom.

Terms, privacy, and disclosures.

Resources

Guides, FAQs & support.

Trading logic, platform rules, and fundamentals.

Connect, authenticate, and build with our API.

Current platform health and incidents.

Loading chart

Pay with

1 BTC

=

- USD

Loading market data...

Loading chart

Pay with

WG

Mkt Cap

$1.90B

Volume

578.58K

Next Earnings

October 27th

Loading chart

WG

WGSGeneDx Holdings Corp. Class A Common Stock

WGS

Pay with—

Available Balance0.00

WG

Mkt Cap

$1.90B

Volume

578.58K

Next Earnings

October 27th

Chart Financials Earnings News About Insider Filings

Encompass Health Expands Rehab Footprint With New Maine HospitalEncompass Health Corporation (EHC) opened its first wholly owned hospital in Maine with 50 inpatient rehabilitation beds. Q2 2026 discharges rose 5.6% year-over-year, driven by new capacity and 2.8% same-store growth. EHC opened three hospitals in the first half of 2026 and plans to open eight new hospitals throughout the year, reflecting its strategy to expand capacity in favorable markets.Zacks Investment Research · Oct 7, 2026

Should You Invest in the State Street SPDR S&P Health Care Services ETF (XHS)?The State Street SPDR S&P Health Care Services ETF (XHS) is a passively managed healthcare services sector ETF with low costs (0.35% expense ratio) and solid year-to-date performance of 27.29%. The fund holds about 62 healthcare companies with a medium risk profile (beta of 0.93) and carries a Zacks ETF Rank of 3 (Hold), making it a reasonable option for investors seeking diversified healthcare sector exposure.Zacks Investment Research · Sep 14, 2026

WGS DEADLINE MONDAY: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages GeneDx Holdings Corp. Investors with Losses in Excess of $100K to Secure Counsel Before Important August 3 Deadline in Securities Class Action - WGSA securities class action lawsuit has been filed against GeneDx Holdings Corp. (WGS) for allegedly making false statements about the Fabric acquisition's impact on the company's financials and operational efficiencies. The lawsuit claims defendants knew of significant problems with Fabric's viability that would negatively impact the business. Investors with losses exceeding $100K are encouraged to join the class action before the August 3, 2026 lead plaintiff deadline.GlobeNewswire Inc. · Aug 1, 2026

מועד אחרון לתביעה הייצוגית נגד ב-WGS ביום שני: רוזן, יועץ מהימן למשקיעים, קורא למשקיעי GeneDx Holdings Corp שספגו הפסדים העולים על 100,000 דולר לקבל ייצוג משפטי לפני המועד החשוב ב-3 באוגוסט במסגרת תביעה ייצוגית בניירות ערך – WGSRosen Law Firm announces a securities class action lawsuit against GeneDx Holdings Corp (WGS) for alleged false statements regarding the Fabric acquisition. The firm claims GeneDx made misleading statements about cost reduction and operational synergies that never materialized, causing investor losses. The deadline to join the class action is August 3, 2026.GlobeNewswire Inc. · Aug 1, 2026

MONDAY DEADLINE: GeneDx Holdings Corp. (WGS) Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP AnnouncesGeneDx Holdings Corp. (WGS) investors with substantial losses have until August 3, 2026 to seek appointment as lead plaintiff in a securities fraud class action lawsuit. The lawsuit alleges that GeneDx made false and misleading statements regarding the viability of its Fabric Genomics acquisition. GeneDx's stock dropped over 49% on May 4, 2026 after revealing a significant drop in adjusted gross margin from 74% to 69%, reduced earnings projections, and a $31.3 million impairment loss directly attributable to Fabric Genomics.GlobeNewswire Inc. · Jul 31, 2026

GeneDx Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against GeneDx Holdings Corp. - WGSGeneDx Holdings Corp. faces a securities class action lawsuit for failing to disclose material information between April 16, 2025 and May 4, 2026. The company reported a significant drop in adjusted gross margin from 74% to 69%, missed revenue estimates, lowered full-year guidance from $540-$550M to $475-$490M, and took a $31.2M impairment loss on its Fabric Genomics acquisition. GeneDx shares fell 49.2% on the announcement. Investors with losses exceeding $100,000 have until August 3, 2026 to file lead plaintiff applications.GlobeNewswire Inc. · Jul 30, 2026

WGS DEADLINE: ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages GeneDx Holdings Corp. Investors to Secure Counsel Before Important August 3 Deadline in Securities Class Action - WGSRosen Law Firm reminds GeneDx Holdings Corp. (NASDAQ: WGS) investors who purchased stock between April 16, 2025 and May 4, 2026 of the August 3, 2026 lead plaintiff deadline in a securities class action. The lawsuit alleges GeneDx made false statements regarding the Fabric acquisition's positive impact on the company's financials and operations, when defendants knew of significant viability problems that would negatively impact the business.GlobeNewswire Inc. · Jul 30, 2026

GeneDx Holdings Securities Fraud Class Action Result of Acquisition Performance Misrepresentations and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLCGeneDx Holdings Corp. faces a securities fraud class action lawsuit for failing to disclose material information about its Fabric Genomics acquisition performance. The company reported a significant drop in adjusted gross margin from 74% to 69%, missed revenue estimates, and took a $31.2 million impairment loss, resulting in a 49.2% stock price decline. Investors who purchased shares between April 16, 2025 and May 4, 2026 can file lead plaintiff applications by August 3, 2026.GlobeNewswire Inc. · Jul 29, 2026

GENEDX HOLDINGS DEADLINE AUGUST 3rd: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against GeneDx Holdings Corp. and Encourages Investors to Contact the FirmA class action lawsuit has been filed against GeneDx Holdings Corp. (NASDAQ: WGS) alleging the company made false statements about Fabric Genomics and overstated the durability of reimbursement rates. On May 4, 2026, GeneDx revealed a $57.5 million operational loss, lowered 2026 revenue guidance by $65 million, and took a $31.3 million write-down on Fabric Genomics. The stock price fell approximately 50% from $67.93 to $34.51 per share. Investors have until August 3, 2026 to apply as lead plaintiff.GlobeNewswire Inc. · Jul 27, 2026

WGS FINAL DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages GeneDx Holdings Corp. Investors to Secure Counsel Before Important August 3 Deadline in Securities Class Action - WGSA securities class action lawsuit has been filed against GeneDx Holdings Corp. (WGS) for allegedly making false statements regarding the Fabric acquisition's impact on the company's financials and operations. Investors who purchased GeneDx common stock between April 16, 2025 and May 4, 2026 may be entitled to compensation. The deadline to serve as lead plaintiff is August 3, 2026.GlobeNewswire Inc. · Jul 26, 2026

to start trading

WG

WGSGeneDx Holdings Corp. Class A Common Stock

WGS

Pay with—

Available Balance0.00

Your PositionYou don't own any WGS yet.

Related Tickers

Earnings